JNJCongressional Stock Trades
Johnson & Johnson
Pharmaceutical Preparations
Congressional stock trades in Johnson & Johnson (JNJ) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
54
Politicians Trading
21
Last Traded
Sep 8, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Lloyd DoggettD | Oct 5, 2026 | Sep 8, 2026 | Buy | $1,001 - $15,000 | +0.54% |
| Ro KhannaD | Aug 7, 2026 | Jul 20, 2026 | Buy | $1,001 - $15,000 | +8.74% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 30, 2026 | Buy | $1,001 - $15,000 | +11.58% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 27, 2026 | Buy | $15,001 - $50,000 | +12.52% |
| Lloyd DoggettD | Jan 2, 2026 | Dec 9, 2025 | Buy | $1,001 - $15,000 | +35.31% |
| Richard McCormickR | Dec 9, 2025 | Nov 5, 2025 | Buy | $1,001 - $15,000 | +45.46% |
| Lisa C. McClainR | Nov 21, 2025 | Oct 30, 2025 | Buy | $1,001 - $15,000 | +43.12% |
| Lisa C. McClainR | Sep 12, 2025 | Aug 4, 2025 | Buy | $1,001 - $15,000 | +58.19% |
| Lisa C. McClainR | Aug 13, 2025 | Jun 17, 2025 | Buy | $1,001 - $15,000 | +77.56% |
| Lloyd DoggettD | Jul 7, 2025 | Jun 10, 2025 | Buy | $1,001 - $15,000 | +72.94% |
| Gilbert Ray Cisneros, Jr.D | Jun 6, 2025 | May 30, 2025 | Buy | $15,001 - $50,000 | +74.32% |
| Marjorie Taylor GreeneR | May 6, 2025 | May 5, 2025 | Buy | $1,001 - $15,000 | +74.55% |
| Bruce WestermanR | Apr 16, 2025 | Mar 3, 2025 | Buy | $1,001 - $15,000 | +61.74% |
| Jefferson ShreveR | Apr 11, 2025 | Mar 5, 2025 | Buy | $15,001 - $50,000 | +63.86% |
| Gilbert Ray Cisneros, Jr.D | Apr 7, 2025 | Mar 31, 2025 | Buy | $15,001 - $50,000 | +63.15% |
| Lloyd DoggettD | Apr 7, 2025 | Mar 4, 2025 | Buy | $1,001 - $15,000 | +63.56% |
| Jefferson ShreveR | Mar 9, 2025 | Feb 24, 2025 | Buy | $15,001 - $50,000 | +65.24% |
| Josh GottheimerD | Feb 10, 2025 | Jan 24, 2025 | Buy | $1,001 - $15,000 | +84.28% |
| Josh GottheimerD | Feb 10, 2025 | Jan 21, 2025 | Buy | $1,001 - $15,000 | +82.63% |
| Josh GottheimerD | Feb 10, 2025 | Jan 16, 2025 | Buy | $1,001 - $15,000 | +83.10% |
| Marjorie Taylor GreeneR | Jan 27, 2025 | Jan 8, 2025 | Buy | $1,001 - $15,000 | +90.17% |
| Marjorie Taylor GreeneR | Jan 27, 2025 | Jan 8, 2025 | Buy | $1,001 - $15,000 | +90.17% |
| Marjorie Taylor GreeneR | Jan 27, 2025 | Jan 8, 2025 | Buy | $1,001 - $15,000 | +90.17% |
Price History
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
21 members of Congress have disclosed 54 trades in Johnson & Johnson (JNJ). Most active: Lisa C. McClain (6), Thomas H. Kean, Jr. (6), Josh Gottheimer (5).
Across all disclosures, members of Congress reported 23 purchases and 31 sales of Johnson & Johnson (JNJ). The most recent trade was on Sep 8, 2026.
Lloyd Doggett disclosed buying Johnson & Johnson (JNJ) on Sep 8, 2026, valued at $1,001 - $15,000.
Thomas H. Kean, Jr. disclosed selling Johnson & Johnson (JNJ) on Aug 27, 2026, valued at $1,001 - $15,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.